Biochemical Society journals S2O decision 2026
News, Mar 02 2026
We’re pleased to announce that two leading review journals from the Biochemical Society will be published open access (OA) during 2026. Publishing and accessing content within these journals will be fee-free for authors and readers respectively. For researchers worldwide this means the broadest reach of their work is achieved.
In 2026 authors can publish fee-free in the following journals:
- Biochemical Society Transactions, Volume 54
- Essays in Biochemistry, Volume 70
We’re grateful to the collective action of our library and institutional customers who support the Subscribe to Open (S2O) model, allowing us to maintain momentum, and offer a route to achieving OA for all authors and readers. The success of this model for these titles, even with external influences impacting the publishing landscape, means we’re able to open journals while still protecting the financial sustainability of the Society and Portland Press.
Our on-going commitment to open access is reflected in our continued offerings in the Biochemical Journal and Clinical Science with agreements guaranteeing fee-free OA via consortia or institutions (Read & Publish institutions – see eligibility list here) and through our green OA policy. While these titles are not open under S2O this year, we’re committed to supporting authors across the globe through the challenging publishing climate.
The success of OA publishing in any year is contingent on renewal thresholds being met for each title and the decision will be reviewed again in 2027.
Publishing revenues from Portland Press, the Biochemical Society’s publishing arm, directly support the Society’s charitable activities, including grant programmes, scientific events, training, career development and community support across the molecular biosciences. The S2O model provides a pragmatic way of supporting researchers to publish OA but is also a method of preserving the Society’s income so it can continue to serve molecular bioscientists at every career stage.
